Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
Retrieved on:
Wednesday, August 4, 2021
SAN DIEGO, Aug. 3, 2021 /PRNewswire/ --Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to helpexpand SARS-CoV-2 sequencing capabilitiesin the region and support the broader genomic surveillance effort across India.
Key Points:
- SAN DIEGO, Aug. 3, 2021 /PRNewswire/ --Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to helpexpand SARS-CoV-2 sequencing capabilitiesin the region and support the broader genomic surveillance effort across India.
- Kasturba Hospital was the first hospital in Mumbai to begin sequencing SARS-CoV-2 this year and will examine how variants of the virus are being spread across India.
- "Illumina believes in democratization of access to sequencing and we are committed to helping the regions of the world that carry most of the infectious disease burden to build genomics capabilities," said Francis deSouza, Chief Executive Officer of Illumina.
- "This donation will help to make NGS technology and expertise accessible in Mumbai, supporting the region and contributing to genomic surveillance in India more broadly."